News about the Innovation Law and Tech Program or news about faculty or students that relates to law and technology
Drug labels required by the U.S. Food and Drug Administration are meant to help ensure safe and effective use of prescription drugs; however, recent court decisions have problematically treated those labels as key evidence in patent infringement cases, with drug companies engaging in what Professor Jacob Sherkow calls “patent gamesmanship” that could potentially limit access […]
Professor Jacob Sherkow recently presented his work on patent infringement at three separate events. He presented a paper, “Compounding Patent Infringement” at the Stanford Patent Scholars Roundtable in January, and in February he presented “Infringement by Drug Label” at the Health Law Colloquium at the Ohio State University Moritz College of Law as well as […]
Replacing animal testing for drug trials is promising, but Professor Sara Gerke and her co-authors on a new paper on the subject believe caution is warranted before adopting change. Gerke recently spoke to the Illinois News Bureau about the paper. “The primary goal of the FDA is to make animal testing the exception in 3-5 […]
As artificial intelligence technology becomes more commonplace, questions about its ethical use are of more salience. In the AMA Journal of Ethics, Professor Sara Gerke examines one area of interest in this field: how ambient listening and transcription technology influences medical doctors’ documentation practices and clinical encounters. In her article, Gerke and her co-author seek […]
“Infringement by label” is when a court treats drug labels as if they were patent claims, assessing whether their text merely “contains” a patented method of use, and it is also the subject of the latest scholarly research from Professor Jacob Sherkow. Writing in the Stanford Law Review, Sherkow explains how infringement by label threatens […]
Professor Sara Gerke has been selected to participate in the Spring 2026 cohort of the NSF CAREER Club. This campus initiative helps equip faculty with knowledge, resources, and writing support necessary to develop a competitive proposal for the National Science Foundation (NSF) Faculty Early Career Program (CAREER). As a participant, Gerke will be provided access to information […]
To help residents with the high cost of insulin, a necessary drug for patients with diabetes, the state of California decided to develop its own generic brand of the medicine. The project will begin distributing “CalRx” insulin to consumers in January, and the San Jose Mercury News spoke to Professor Jacob Sherkow about how this […]
Many recent changes in rules and regulations surrounding nuclear power reactors have been enacted with the goal of expanding the use of nuclear technology, but the shifts also run the risk of overwhelming the Nuclear Regulatory Commission and threatening the industry. In a new editorial published by Nuclear Newswire, Professor Arden Rowell and a team […]
Professor Jacob Sherkow has co-authored a new paper with Laura Valtere (University of Copenhagen – CeBIL) and Timo Minssen (University of Copenhagen – CeBIL) titled “Intellectual Property, New Genomic Technologies And Plant Innovation: Clearing Innovation Pathways.” The abstract follows: New genomic technologies (NGTs), such as genome editing-the modification of DNA in living cells-promises to revolutionize […]
On November 11, 2025, Jacob S. Sherkow was invested as the Richard W. and Marie L. Corman Professor of Law in a ceremony honoring his commitment to scholarship, teaching, and public engagement. In remarks shared at the ceremony, Dean Jamelle Sharpe said, “Professor Sherkow’s achievements—and the real-world impact of his work—represent the very best of […]